Form SCHEDULE 13G/A Alkermes plc. Filed by: WELLINGTON MANAGEMENT GROUP LLP

Go back to Form SCHEDULE 13G/A Alkermes plc. Filed by: WELLINGTON MANAGEMENT GROUP LLP

Jefferies Reiterates Buy Rating on Alkermes (ALKS)

February 12, 2025 1:18 PM EST

Jefferies analyst Akash Tewari reiterated a Buy rating and $41.00 price target on Alkermes (NASDAQ: ALKS).

The analyst comments "ALKS reported a beat in Q4 on both total revs ($430M vs $356M cons) & non-GAAP EPS ($1.04 vs $0.72 cons) - Lybalvi revs were $77M... More